九典制药：对消炎解痛巴布膏的市场前景持乐观态度

Group 1 - The core viewpoint of the article is that Jiutian Pharmaceutical (300705) is optimistic about the market prospects for its anti-inflammatory and analgesic plaster, primarily focusing on OTC channels for sales [1] - The company plans to enhance sales of the anti-inflammatory and analgesic plaster and other new products by concentrating on OTC channels, sharing sales resources, and enriching its product matrix [1] - The aging population is expected to lead to a continuous increase in the chronic pain patient demographic, which will further drive the market demand for transdermal drug delivery products [1]